NCT06055881View on ClinicalTrials.gov

Primary Breast Oligoprogressive Sites Treated With Radiotherapy to Obviate the Need to Change Systemic Therapy

NARecruitingINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

October 23, 2023

Primary Completion Date

October 30, 2026

Study Completion Date

October 30, 2026

Conditions
Breast CarcinomaAnatomic Stage IV Breast Cancer AJCC v8Metastatic Breast Cancer
Interventions
PROCEDURE

Biospecimen Collection

Undergo blood sample collection

OTHER

Surveys

"Patients complete the European Quality of Life 5 Dimensions 5 Level Version (EQ-5D-5L) survey and Was it Worth It questionnaire."

RADIATION

Stereotactic Body Radiation Therapy (SBRT)

Patients receive stereotactic body radiation therapy (SBRT), metastasis-directed radiation therapy .

PROCEDURE

Computed Tomography

Undergo CT, MRI and/or PET/CT

PROCEDURE

Magnetic Resonance Imaging

Undergo CT, MRI and/or PET/CT

PROCEDURE

Positron Emission Tomography

Undergo CT, MRI and/or PET/CT

Trial Locations (2)

55905

RECRUITING

Mayo Clinic in Rochester, Rochester

85259

RECRUITING

Mayo Clinic in Arizona, Scottsdale

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT06055881 - Primary Breast Oligoprogressive Sites Treated With Radiotherapy to Obviate the Need to Change Systemic Therapy | Biotech Hunter | Biotech Hunter